Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd (TLSA) Implied Volatility Current
TLSA implied volatility is 51%. IV Rank is 24%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking TLSA implied volatility helps you identify when options premiums on Tiziana Life Sciences Ltd are historically cheap or expensive, and where the best trades are hiding. Tiziana Life Sciences Ltd implied volatility reflects the market's expectation of future price movement: when TLSA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Tiziana Life Sciences Ltd's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TLSA, tracking metrics like TLSA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TLSA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients.
The company was incorporated in 1998 and is headquatered in London, the United Kingdom.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TLSA implied volatility sits today versus where it has been. Our scanner ranks Tiziana Life Sciences Ltd implied volatility against its historical range, surfaces extremes in TLSA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Tiziana Life Sciences Ltd IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 22, 2026
Trade options with IV on your side
Track TLSA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→